David Cook Net Worth & Insider Trades
David Cook - See Remarks, Seres Therapeutics, Inc
What is David Cook's Net Worth?
The current estimated net worth of Seres Therapeutics, Inc's See Remarks, David Cook, is estimated to be about $3.44M . David Cook owns about 139,935 units of Seres Therapeutics, Inc common stock. In the last 3 years at Seres Therapeutics, Inc, David Cook has sold an estimated value of $2.58M worth.
What is David Cook's Past Insider Trading?
David Cook's largest sale order was 61,000 units , worth over $1.6M on April 5, 2016. In total, David Cook has made about 8 transactions over 3 years of their time at Seres Therapeutics, Inc. David Cook usually trades in June, with the busiest year in 2016. The most recent transaction was a sale order of 1,738 units , worth over $19.15K on January 30, 2018.
David N Cook
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was David Cook's Salary in 2020?
As See Remarks of Seres Therapeutics, Inc, David Cook has a total base salary of $76,923 . David Cook received compensation valued at about $5,318,587 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of a bonus of $65,000 , option awards of $5,175,880 , other compensation of $785 .
Seres Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Eric D. Shaff | 2020 | $590,000 | - | $2,050,600 | $486,750 | $8,550 | $3,135,900 |
| Eric D. Shaff | 2019 | $540,000 | - | $1,231,148 | $253,000 | $8,400 | $2,032,548 |
| Thomas J. DesRosier | 2020 | $450,000 | - | $717,710 | $261,000 | $8,550 | $1,437,260 |
| Thomas J. DesRosier | 2019 | $428,300 | - | $379,641 | $161,000 | $8,400 | $977,341 |
| David S. Ege, Ph.D. | 2020 | $76,923 | $65,000 | $5,175,880 | - | $785 | $5,318,587 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1609809/000119312521144988/d77986ddef14a.htm
What are Seres Therapeutics, Inc's Past Insider Trades?
Seres Therapeutics, Inc's most recent insider trade came on July 7, 2022 by Nutritional Health Ltp Fund General Partner Llc, Nutritional Health Ltp Fund Lp, Flagship Pioneering Inc and Noubar Afeyan who bought 8,738,243 units worth $27.53M . In the last 6 years, insiders at Seres Therapeutics, Inc have sold an estimated value of $57.94M and bought an estimated value of $75.14M worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Roger Pomerantz, Director, John G Aunins, Chief Technology Officer & EVP, and Eric D Shaff, CEO and President .
Seres Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||